Systematic review of tofacitinib: A new drug for the management of rheumatoid arthritis

Clinical Therapeutics

Volumn 36, Issue 7, 2014, Pages 1074-1086

  Kaur, Kirandeep ^a   Kalra, Sonesh ^a   Kaushal, Sandeep ^a  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Janus kinase; rheumatoid arthritis; tofacitinib

Indexed keywords

ADALIMUMAB; PLACEBO; TOFACITINIB; ANTIRHEUMATIC AGENT; METHOTREXATE; PIPERIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

DAS28; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX; HUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SHARP VAN DER HEIJDE SCORE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ARTHRITIS, RHEUMATOID; CLINICAL TRIAL (TOPIC); DRUG COMBINATION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; HUMANS; METHOTREXATE; PIPERIDINES; PYRIMIDINES; PYRROLES; TREATMENT OUTCOME;

EID: 84904733767     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2014.06.018     Document Type: Review

References (26)

1. Harrison's Principles of Internal Medicine D.L. Longo, D.L. Kasper, and J.L. Jameson 18th ed 2012 McGraw Hill New York
2. J.S. Smolen, R. Landewe, and F.C. Breedveld et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs-2013 update Ann Rheum Dis 73 2013 492 509
3. D.S. Pisetsky, and M.M. Ward Advances in the treatment of inflammatory arthritis Best Pract Res Clin Rheumatol 26 2012 251 261
4. F. Brandão, P. Coelho, P. Pinto, and B. Combe Tocilizumab - a new step in rheumatoid arthritis treatment Acta Rheumatol Port 35 2010 302 312
5. J.A. Singh, D.E. Furst, and A. Bharat et al. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis Arthritis Care Res 64 2012 625 639
6. J.M. Davis, and E.L. Matteson My treatment approach to rheumatoid arthritis Mayo Clin Proc 87 2012 659 673
7. Y. Yazici, and A.L. Regens Promising new treatments for rheumatoid arthritis: the kinase inhibitors Bull NYU Hosp Jt Dis 69 2011 233 237
8. A. Liberati, D.G. Altman, and J. Tetzlaff et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration PLoS Med 6 7 2009 e1000100
9. US Food and Drug Administration. http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm327152.htm. Accessed March 14, 2014.
10. D.M. Lee, and M.E. Weinblatt Rheumatoid arthritis Lancet 358 2001 903 911
11. T. Grosser, E. Smyth, and G.A. Fitzgerald Anti-inflammatory antipyretic and analgesic agents; Pharmacotherapy of gout L.L. Brunton, B.A. Chabner, B.C. Knollmann, Goodman & Gilman's The Pharmacological Basis of Therapeutics 2011 McGrawHill New York 959 1004
12. H.P. Rang, M.M. Dale, and J.M. Ritter et al. Anti-inflammatory and immunosuppressant drugs H.P. Rang, M.M. Dale, J.M. Ritter, Rang and Dale's Pharmacology 2012 Elsevier London 326
13. F.C. Arnett, S.M. Edworthy, and D.A. Bloch et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 1988 315 324
14. D.T. Felson, J.J. Anderson, and M. Boers et al. American College of Rheumatology: preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 1995 727 735
15. M.L. Prevoo, M.A. van't Hof, and H.H. Kuper et al. Modified Disease Activity Scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 1995 44 48
16. R.F. Van Vollenhoven, R. Fleischmann, and S. Cohen et al. Tofacitinib or adalimumab versus placebo in rheumatoid arthritis N Engl J Med 367 2012 508 519
17. D. Van der Heijde, Y. Tanaka, and R. Fleischmann et al. Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve month data from a twenty four month phase III randomized radiographic study Arthritis Rheum 65 2013 559 570
18. R. Fleischmann, J. Kremer, and J. Cush et al. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis N Engl J Med 367 2012 495 507
19. G.R. Burmester, R. Blanco, and C. Charles-Schoeman et al. Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomized phase 3 trial Lancet 381 2013 451 460
20. J.M. Kremer, B.J. Bloom, and F.C. Breedveld et al. The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis Arthritis Rheum 60 2009 1895 1905
21. Y. Tanaka, M. Suzuki, and H. Nakamura et al. Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate Arthritis Care Res 63 2011 1150 1158
22. R. Fleischmann, M. Cutolo, and M.C. Genovese et al. Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs Arthritis Rheum 64 2012 617 629
23. J.M. Kremer, S. Cohen, and B.E. Wilkinson et al. A Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone Arthritis Rheum 64 2012 970 981
24. E.B. Lee, R. Fleischmann, S. Hall, B. Wilkinson, J.D. Bradley, and D. Gruben et al. ORAL Start Investigators. Tofacitinib versus methotrexate in rheumatoid arthritis N Engl J Med 370 2014 2377 2386
25. Clinical trials.gov. http://www.clinicaltrials.gov/ct2/show/NCT00413699? term=tofacitinib+rheumatoid+arthritis&rank=8. Accessed November 13, 2013.
26. Xeljanz [package insert]. http://www.xeljanzhcp.com/. Accessed November 26, 2013.